Global Sleep Aid Supplements Market Overview:
The amount of sleep a person needs can vary from person to person. According to Centres for Disease Control and Prevention; the recommended sleep for adults is 7-8 hours per day. According to the one out of three adults nowadays do not get enough sleep. Occasional lack of sleep may not be harmful but constant lack of quality sleep can affect a personís performance in work-life or even their ability to do day-to-day tasks. Symptoms of sleep deprivation include fatigue, irritability, mood changes among several other things. Due to this sleep aid supplements are used to tackle insomnia. Sleep aid supplements are generally, consumed after dinner before sleeping to induce sleep. Due to increasing anxiety and insomnia among adults, the demand for sleep aid supplements is rising.
- Increasing Sleep Deprivation Among the Adults Boosting the Demand of Sleep Aid Supplements
- Increasing Work Hours in Corporate Culture Leading to Lack of Sleep
- Increasing Use of Natural Sleep Aid Supplements
- Growing Use of Prescribed Medication to Counter Sleep Loss
- Side Effects of Sleep Aid Supplements Could Be Harmful
- Increasing Demand from Countries with Big Corporate WorkForce Like India, Us, and China
- Inconsistent Sleep Timings Leading to Use of Sleep Aid Supplements
- Negative Public Opinion About Use of Sleep Aid Supplements
- Lack of Research on The Subject of Sleep Aid Supplements
Some of the key players profiled in the report are Pfizer (United States), Sanofi Aventis (France), Sumitomo Dainippon Pharma (Japan), Lupin Limited (India), King Bio (United States), Takeda Pharmaceutical (Japan), Merck (United States), NutraClick (United States), Philips (Netherlands), SleepMed Inc. (United States) and Fiji Kava (Australia). Considering Market by Nature, the sub-segment i.e. Natural will boost the Sleep Aid Supplements market. Considering Market by Sales Channel, the sub-segment i.e. Retail Stores will boost the Sleep Aid Supplements market. Considering Market by Age, the sub-segment i.e. 18 years to 60 Years will boost the Sleep Aid Supplements market.
In June 2020, Fiji Kavaís new sleep and relax range of Kava Supplements became available in nearly 600 Coles Supermarkets. The range also became available in Coles online. The new range is in form of vegan capsules serving three different needs namely aiding sleep, mind relaxation, and relieving muscle cramps. According to their CEO, this is a significant milestone in Fiji Kavaís journey to increase its retail distribution.
CRN in the USA has issued various guidelines regarding the Manufacturing and Labelling of Sleep Aid Supplements according to which, the serving size should not more than 10mg. The product labels should include advice for consulting healthcare professionals. Also, warning regarding driving and operating machinery while taking the sleep aid.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Sleep Aid Supplements market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Sleep Aid Supplements market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Sleep Aid Supplements Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.